• Arteris Announces Financial Results for the Third Quarter 2022 and Estimated Fourth Quarter and Full Year 2022 Guidance

    来源: Nasdaq GlobeNewswire / 08 11月 2022 16:05:02   America/New_York

    CAMPBELL, Calif., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Arteris, Inc. (Arteris or Arteris IP), a leading provider of network-on-chip (NoC) interconnect and other intellectual property (IP) technology that manages the on-chip communications in system-on-chip (SoC) semiconductor devices, today announced financial results for the third quarter ended September 30, 2022 as well as estimated fourth quarter and full year 2022 guidance.

    “We’re excited by our results for the third quarter, including both Annual Contract Value plus Trailing-Twelve-Month Royalties of $53.2 million, up 17% year-over-year and the achievement of a major company milestone with over three billion systems shipped with SoCs connected by Arteris System IP," said K. Charles Janac, President and CEO of Arteris IP. “While there are macro-economic uncertainties, including the latest US Commerce Department regulations with respect to China, we believe that Arteris is well positioned as our customers are continuing to innovate in areas such as automotive, machine learning and 5G, driving the need for increased use of commercial System IP.”

    Third Quarter 2022 Financial Highlights:

    • Annual Contract Value (ACV) and Trailing-twelve-month (TTM) royalties of $53.2 million, up 17% year-over-year
    • Revenue of $12.6 million, up 41% year-over-year
    • Remaining performance obligation (RPO) of $59.3 million, up 17% year-over-year
    • Operating loss of $7.8 million or 61% of revenue
    • Non-GAAP operating loss of $4.2 million or 34% of revenue, compared to a Non-GAAP operating loss of $4.0 million in the year-ago period
    • Net loss of $7.7 million or $0.23 per share
    • Non-GAAP net loss of $4.2 million or $0.13 per share
    • Non-GAAP free cash flow of $(5.7) million or (45)% of revenue

    Third Quarter 2022 Business Highlights:

    • Added 10 Active Customers in the third quarter across some of our core market verticals, including a deal with a major international electric vehicle manufacturer, and a deal with a space-oriented customer;
    • We announced an expanded partnership with Arm to help speed up automotive electronics innovation, leveraging Arm processors and Arteris System IP to enable a variety of high-performance automotive semiconductors;
    • 21 confirmed design starts in the third quarter, including in automotive, consumer, and mobile infrastructure;
    • We announced our collaboration with SiMa.ai, which integrates the Arteris FlexNoC interconnect IP into the SiMa.ai Machine Learning System-on-Chip (MLSoC) for implementing AI/ML computing at the edge;
    • We achieved a major company milestone of reaching over three billion systems shipped with SoCs connected by Arteris System IP since inception; and
    • We strengthened our management team with the addition of Christel Mauffet-Smith as our new Executive Vice President of Global Sales.

    Estimated Fourth Quarter and Full Year 2022 Guidance:

     Q4 2022FY 2022
     (in millions, except %)
    ACV + TTM royalties$47.5 - $51.5$47.5 - $51.5
    Revenue$10.8 - $11.8$50.0 - $51.0
    Non-GAAP operating loss (%)50.2% - 70.2%31.6% - $36.1%
    Free cash flow (%)(47.1)% - (13.1)%(24.6)% - (16.6)%

    The guidance provided above are forward-looking statements and reflect our expectations as of today's date. Actual results may differ materially. Refer to the section titled "Forward-Looking Statements" below for information on the factors, among others, that could cause our actual results to differ materially from these forward-looking statements.

    Non-GAAP gross profit, Non-GAAP gross margin, Non-GAAP operating loss, Non-GAAP operating loss margin, Non-GAAP net loss, Non-GAAP net loss per share, free cash flow and free cash flow margin are Non-GAAP financial measures. Additional information on Arteris’ historic reported results, including a reconciliation of these Non-GAAP financial measures to their most comparable GAAP measures, is included in the financial tables below. A reconciliation of Non-GAAP guidance measures reported above to corresponding GAAP measures is not available on a forward-looking basis without unreasonable effort due to the uncertainty of expenses that may be incurred in the future, although it is important to note that these factors could be material to Arteris' results computed in accordance with GAAP.

    Definitions of the other business metrics used in this press release including ACV, active customers, confirmed design starts and RPO are included below under the heading “Other Business Metrics.”

    Conference Call

    Arteris will host a conference call today, November 8, 2022, to review its third quarter 2022 financial results and to discuss its financial outlook.

     Time:4:30PM ET
     United States/Canada Toll Free:800-926-7563
     International Toll:1-212-231-2914
     Conference ID:22021047

    A live webcast will also be available in the Investor Relations section of Arteris’ website at: https://ir.arteris.com/events-and-presentations

    A replay of the webcast will be available in the Investor Relations section of the company’s web site approximately two hours after the conclusion of the call and remain available for approximately 30 calendar days.

    About Arteris

    Arteris IP (Nasdaq: AIP) provides system-on-chip (SoC) system IP consisting of network-on-chip (NoC) interconnect IP and IP deployment technology to accelerate system-on-chip (SoC) semiconductor development and integration for a wide range of applications from AI to automobiles, mobile phones, IoT, cameras, SSD controllers, and servers for customers such as Bosch, Mobileye, Samsung, Toshiba and NXP. Arteris IP products include the Ncore® cache coherent and FlexNoC® non-coherent interconnect IP, the CodaCache® standalone last level cache, and optional Resilience Package (ISO 26262 functional safety), FlexNoC AI Package, and PIANO® automated timing closure capabilities. Our IP deployment products provide intelligent automation that accelerates the development and increases the quality of SoC hardware designs and their associated software and firmware, verification and simulation platforms, and specifications and customer documentation. Customer results obtained by using Arteris IP products include lower power, higher performance, more efficient design reuse and faster SoC development, leading to lower development and production costs.

    Investor Contacts:
    Arteris
    Nick Hawkins
    Chief Financial Officer
    IR@arteris.com

    Sapphire Investor Relations
    Erica Mannion and Michael Funari
    +1 617 542 6180
    IR@arteris.com

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including but not limited to, statements regarding our future financial and operating performance, including our GAAP and Non-GAAP guidance for the fourth quarter and full year 2022; our market opportunity and its potential growth; our position within the market and our ability to drive customer value; and our ability to make progress even in a challenging economic environment. The words "may," "might," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "expect," "estimate," "seek," "predict," "future," "project," "potential," "continue," "target" and similar words or expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Any forward-looking statements contained herein are based on our historical performance and our current plans, estimates and expectations and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent our expectations as of the date of this press release. Subsequent events may cause these expectations to change, and we disclaim any obligation to update the forward-looking statements in the future, except as required by law. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially from our current expectations. Important factors that could cause actual results to differ materially from those anticipated in our forward-looking statements include, but are not limited to, the significant competition we face from larger companies and third-party providers; our history of net losses; whether semiconductor companies in the automotive market, AI/ML market, 5G and wireless communications market, large scale cloud and data center market and consumer electronics market incorporate our solutions into their end products and the growth and economic stability of these end markets; our ability to attract new customers and the extent to which our customers renew their subscriptions for our solutions; the ability of our customers’ end products achieving market acceptance or growth; our ability to sustain or grow our licensing revenue; our ability, and the cost, to successfully execute on research and development efforts; the occurrence of product errors or defects in our solutions; if we fail to offer high-quality support; the occurrence of macro-economic conditions that adversely impact us, the effects of geopolitical conflicts, such as the military conflict between Russia and Ukraine, our customers and their end product markets; the range of regulatory, operational, financial and political risks we are exposed to as a result of our dependence on international customers and operations; our ability to protect our proprietary technology and inventions through patents and other IP rights; whether we are subject to any liabilities or fines as a result of government regulation, including import, export and economic sanctions laws and regulations; the occurrence of a disruption in our networks or a security breach; risks associated with doing business in China; and the other factors described under the heading “Risk Factors” in our Quarterly Report on Form 10-Q for the quarter ended September 30, 2022 to be filed with the Securities and Exchange Commission (SEC) on November 8, 2022. All forward-looking statements reflect our beliefs and assumptions only as of the date of this press release. We undertake no obligation to update forward-looking statements to reflect future events or circumstances. Our results for the quarter ended September 30, 2022 are not necessarily indicative of our operating results for any future periods.


    Arteris, Inc.

    Condensed Consolidated Statements of Loss
    (In thousands, except share and per share data)
    (Unaudited)

     Three Months Ended
    September 30,
     Nine Months Ended
    September 30,
      2022   2021   2022   2021 
    Revenue       
    Licensing, support and maintenance$11,135  $8,136  $35,743  $24,353 
    Variable royalties and other 1,463   823   3,432   2,077 
    Total revenue 12,598   8,959   39,175   26,430 
    Cost of revenue (1) 928   883   3,196   2,618 
    Gross profit 11,670   8,076   35,979   23,812 
    Operating expenses:       
    Research and development (1) 11,022   7,609   30,849   20,572 
    Sales and marketing (1) 4,411   3,242   12,788   7,971 
    General and administrative (1) 3,991   1,742   12,138   9,754 
    Total operating expenses 19,424   12,593   55,775   38,297 
    Loss from operations (7,754)  (4,517)  (19,796)  (14,485)
    Interest and other income (expense), net 318   (183)  346   (497)
    Loss before provision for income taxes (7,436)  (4,700)  (19,450)  (14,982)
    Provision for income taxes 248   268   722   612 
    Net loss$(7,684) $(4,968) $(20,172) $(15,594)
            
    Net loss per share attributable to common stockholders, basic and diluted$(0.23) $(0.24) $(0.63) $(0.79)
    Weighted average shares used in computing per share amounts, basic and diluted 32,836,014   20,578,386   32,228,429   19,768,574 

    (1) Includes stock-based compensation expense as follows:

     Three Months Ended Nine Months Ended
     September 30, September 30,
      2022  2021  2022  2021
     (in thousands)
    Cost of revenue$118 $15 $474 $42
    Research and development 1,798  225  4,435  645
    Sales and marketing 679  23  1,678  72
    General and administrative 794  170  2,495  385
    Total stock-based compensation expense$3,389 $433 $9,082 $1,144


    Arteris, Inc.

    Condensed Consolidated Balance Sheets
    (In thousands, except share and per share data)
    (Unaudited)

     As of
     September 30, 2022 December 31, 2021
    ASSETS   
    Current assets:   
    Cash and cash equivalents$68,200  $85,825 
    Short-term investments 4,400    
    Accounts receivable, net 9,638   13,873 
    Prepaid expenses and other current assets 8,427   6,949 
    Total current assets 90,665   106,647 
    Property and equipment, net 3,502   2,438 
    Long-term investments 1,983    
    Equity method investment 12,181    
    Operating lease right-of-use assets 2,124   2,765 
    Intangibles, net 2,575   2,959 
    Goodwill 2,677   2,677 
    Other assets 3,115   2,957 
    TOTAL ASSETS$118,822  $120,443 
    LIABILITIES AND STOCKHOLDERS’ EQUITY   
    Current liabilities:   
    Accounts payable$1,984  $1,722 
    Accrued expenses and other current liabilities 11,520   10,573 
    Operating lease liabilities, current 1,033   961 
    Deferred revenue, current 27,646   28,403 
    Vendor financing arrangements, current 1,502   833 
    Total current liabilities 43,685   42,492 
    Deferred revenue, noncurrent 22,046   20,773 
    Operating lease liabilities, noncurrent 1,134   1,851 
    Vendor financing arrangements, noncurrent 433   266 
    Deferred income, noncurrent 10,290    
    Other liabilities 877   2,157 
    Total liabilities 78,465   67,539 
    Stockholders' equity:   
    Preferred stock, par value of $0.001 - 10,000,000 shares authorized and no shares issued and outstanding as of September 30, 2022 and December 31, 2021     
    Common stock, par value of $0.001 - 300,000,000 shares authorized as of September 30, 2022 and December 31, 2021; 33,320,891 and 31,530,682 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively 33   31 
    Additional paid-in capital 99,589   91,945 
    Accumulated other comprehensive loss (102)  (81)
    Accumulated deficit (59,163)  (38,991)
    Total stockholders' equity 40,357   52,904 
    TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY$118,822  $120,443 


    Arteris, Inc.

    Condensed Consolidated Statements of Cash Flows
    (In thousands)
    (Unaudited)

     Nine Months Ended
    September 30,
     2022
     2021
    CASH FLOWS FROM OPERATING ACTIVITIES:   
    Net loss$(20,172) $(15,594)
    Adjustments to reconcile net loss to net cash used in operating activities:   
    Depreciation and amortization 1,568   1,107 
    Stock-based compensation 9,082   1,144 
    Operating non-cash lease expense (4)  (32)
    Amortization of deferred income (94)   
    Gain on deconsolidation of subsidiary (149)   
    Other, net 10   (8)
    Changes in operating assets and liabilities:   
    Accounts receivable, net 4,234   6,226 
    Prepaid expenses and other assets (1,799)  (3,932)
    Accounts payable 408   415 
    Accrued expenses and other liabilities 23   1,328 
    Deferred revenue 517   5,340 
    Net cash used in operating activities (6,376)  (4,006)
    CASH FLOWS FROM INVESTING ACTIVITIES:   
    Purchases of property and equipment (655)  (488)
    Payments relating to investment in equity method investment (520)   
    Purchases of available-for-sale securities (6,399)   
    Proceeds from principal portion of related party loan 241    
    Net cash used in investing activities (7,333)  (488)
    CASH FLOWS FROM FINANCING ACTIVITIES:   
    Payments of contingent consideration for business acquisition (1,573)   
    Proceeds from issuance of common stock    5,435 
    Principal payments under vendor financing arrangements (635)  (418)
    Proceeds from exercise of stock options 601   330 
    Payments to tax authorities for shares withheld from employees (2,053)   
    Payments of deferred offering costs (256)  (906)
    Payments of principal portion of term loan    (450)
    Net cash (used in) provided by financing activities (3,916)  3,991 
    NET DECREASE IN CASH AND CASH EQUIVALENTS (17,625)  (503)
    CASH AND CASH EQUIVALENTS, beginning of period 85,825   11,744 
    CASH AND CASH EQUIVALENTS, end of period$68,200  $11,241 

    Non-GAAP Financial Measures

    To supplement our financial results, which are prepared and presented in accordance with GAAP, we use certain Non-GAAP financial measures, as described below, to understand and evaluate our core performance. These Non-GAAP measures, which may be different than similarly-titled measures used by other companies, are presented to enhance investors’ overall understanding of our financial performance and should not be considered a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP.

    We define "Non-GAAP Gross Profit and Non-GAAP Gross Margin" as GAAP gross profit and GAAP gross margin, adjusted for stock-based compensation expense included in cost of revenue. We define “Non-GAAP Loss from Operations” as our income (loss) from operations adjusted to exclude stock-based compensation, acquisition costs and amortization of acquired intangible assets. We define “Non-GAAP Net Loss” as our net income (loss) adjusted to exclude stock-based compensation, acquisition costs, amortization of acquired intangible assets and gain on extinguishment of debt.

    We define “Non-GAAP EPS”, as our Non-GAAP Net Income (Loss) divided by our GAAP weighted-average number of shares outstanding for the period on a diluted basis. Management uses Non-GAAP EPS to evaluate the performance of our business on a comparable basis from period to period.

    The above items are excluded from our Non-GAAP Gross Profit, Non-GAAP Income (Loss) from Operations and Non-GAAP Net Income (Loss) because these items are non-cash in nature, or are not indicative of our core operating performance, and render comparisons with prior periods and competitors less meaningful. We believe Non-GAAP Gross Profit, Non-GAAP Income (Loss) from Operations and Non-GAAP Net Income (Loss) provide useful supplemental information to investors and others in understanding and evaluating our results of operations, as well as provide a useful measure for period-to-period comparisons of our business performance.

    We define free cash flow as net cash (used in) provided by operating activities less cash used for purchases of property and equipment. We believe that free cash flow is a useful indicator of liquidity that provides information to management and investors, even if negative, about the amount of cash used in our operations other than that used for investments in property and equipment.

    Other Business Metrics

    Annual Contract Value (ACV) – we define Annual Contract Value for an individual customer agreement as the total fixed fees under the agreement divided by the number of years in the agreement term. Our total ACV is the aggregate ACVs for all our customers as measured at a given point in time. Total fixed fees includes licensing, support and maintenance and other fixed fees under IP licensing or software licensing agreements but excludes variable revenue derived from licensing agreements with customers, particularly royalties. We monitor ACV to measure our success and believe the increase in the number shows our progress in expanding our customers’ adoption of our solutions. ACV fluctuates due to a number of factors, including the timing, duration and dollar amount of customer contracts.

    Active Customers – we define Active Customers as customers who have entered into a license agreement with us that remains in effect. The retention and expansion of our relationships with existing customers are key indicators of our revenue potential.

    Confirmed Design Starts – we define Confirmed Design Starts as when customers confirm their commencement of new semiconductor designs using our interconnect IP and notify us. Confirmed Design Starts is a metric management uses to assess the activity level of our customers in terms of the number of new semiconductor designs that are started using our interconnect IP in a given period. We believe that the number of Confirmed Design Starts is an important indicator of the growth of our business and future royalty revenue trends.

    Remaining Performance Obligations (RPO) – we define Remaining Performance Obligations as the amount of contracted future revenue that has not yet been recognized, including both deferred revenue and contracted amounts that will be invoiced and recognized as revenue in future periods.


    Arteris, Inc.

    Reconciliation of GAAP Measures to Non-GAAP Measures
    (In thousands, except percentages, share and per share data)
    (Unaudited)

    Non-GAAP Gross Profit and Gross Margin

     Three Months Ended
    September 30,
     Nine Months Ended
    September 30,
     2022
     2021
     2022
     2021
    Gross profit$11,670  $8,076  $35,979  $23,812 
    Add:       
    Stock-based compensation expense included in cost of revenue (1) 118   15   474   42 
    Non-GAAP gross profit$11,788  $8,091  $36,453  $23,854 
    Gross margin 93%  90%  92%  90%
    Non-GAAP gross margin 94%  90%  93%  90%

    (1) See table in footnote (1) to the condensed consolidated statements of loss above for breakdown of stock-based compensation expense by line item.

    Non-GAAP Loss from Operations

     Three Months Ended
    September 30,
     Nine Months Ended
    September 30,
     2022
     2021
     2022
     2021
    Loss from operations$(7,754) $(4,517) $(19,796) $(14,485)
    Add:       
    Stock-based compensation expense (1) 3,389   433   9,082   1,144 
    Acquisition costs (2)          238 
    Amortization of acquired intangible assets (3,4) 119   119   358   358 
    Non-GAAP loss from operations$(4,246) $(3,965) $(10,356) $(12,745)

    (1) See table in footnote (1) to the condensed consolidated statements of loss above for breakdown of stock-based compensation expense by line item.
    (2) Includes advisory, legal, accounting, valuation, and other professional or consulting fees associated with the Magillem acquisition and recorded in general and administrative.
    (3) Represents the amortization expenses of our intangible assets attributable to the Magillem acquisition.
    (4) Includes amortization of acquired intangible assets as follows:


     Three Months Ended Nine Months Ended
     September 30, September 30,
     2022 2021 2022 2021
    Research and development$85 $85 $255 $255
    Sales and marketing 34  34  103  103
    Total amortization$119 $119 $358 $358


    Non-GAAP Net Loss and Non-GAAP EPS, Basic and Diluted

     Three Months Ended
    September 30,
     Nine Months Ended
    September 30,
     2022
     2021
     2022
     2021
    Net loss$(7,684) $(4,968) $(20,172) $(15,594)
    Add:       
    Stock-based compensation expense (1) 3,389   433   9,082   1,144 
    Acquisition costs (2)          238 
    Amortization of acquired intangible assets (3,4) 119   119   358   358 
    Gain on extinguishment of debt          (10)
    Non-GAAP net loss (5)$(4,176) $(4,416) $(10,732) $(13,864)
            
    Net loss per share attributable to common stockholders, basic and diluted$(0.23) $(0.24) $(0.63) $(0.79)
    Per share impacts of adjustments to net loss (6)$0.10  $0.03  $0.30  $0.09 
    Non-GAAP EPS, basic and diluted$(0.13) $(0.21) $(0.33) $(0.70)
            
    Weighted average shares used in computing per share amounts, basic and diluted 32,836,014   20,578,386   32,228,429   19,768,574 

    (1) See table in footnote (1) to the condensed consolidated statements of loss above for breakdown of stock-based compensation expense by line item.
    (2) Includes advisory, legal, accounting, valuation, and other professional or consulting fees associated with the Magillem acquisition and recorded in general and administrative.
    (3) Represents the amortization expenses of our intangible assets attributable to the Magillem acquisition.
    (4) See table in footnote (4) to the Non-GAAP Loss from Operations above for breakdown of amortization of acquired intangible assets by line item.
    (5) Our GAAP tax provision is primarily related to foreign withholding taxes and income tax in profitable foreign jurisdictions. We maintain a full valuation allowance against our deferred tax assets in the US. Accordingly, there is no significant tax impact associated with these Non-GAAP adjustments.
    (6) Reflects the aggregate adjustments made to reconcile Non-GAAP Net Loss to our net loss as noted in the above table, divided by the GAAP diluted weighted average number of shares of the relevant period.


    Free Cash Flow

     Nine Months Ended
    September 30,
     2022
     2021
    Net cash used in operating activities$(6,376) $(4,006)
    Less:   
    Purchases of property and equipment (655)  (488)
    Free cash flow$(7,031) $(4,494)
    Net cash used in investing activities$(7,333) $(488)
    Net cash (used in) provided by financing activities$(3,916) $3,991 

    Primary Logo

分享